Monday, 19 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

DNO Stock Went Up By Over 13% So Far Today

Loading stream...

(VIANEWS) - Shares of DNO (Oslo Børs Benchmark Index_GI: DNO.OL) rose by a staggering 13.73% to kr11.68 at 11:24 EST on Monday, after four sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI is rising 1.16% to kr1,207.38, after five successive sessions in a row of gains. This seems, up to now, an all-around up trend trading session today.

About DNO

DNO ASA engages in the exploration, development, and production of oil and gas assets in the Middle East, the North Sea, and West Africa. Its flagship project is the Tawke field that is located in the Kurdistan region of Iraq. The company was founded in 1971 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, DNO has a trailing twelve months EPS of kr-2.43.

Volume

Today's last reported volume for DNO is 4916572 which is 28.66% above its average volume of 3821230.

More news about DNO (DNO.OL).

Categories

stockMarket

Tags

Stock PriceMarket Session NowDNO.OLStock Market NowPrice UpDNOMarket SessionStock Price UpStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com